High-b-value diffusion-weighted MR imaging for pretreatment prediction and early monitoring of tumor response to therapy in mice.
about
Fractional change in apparent diffusion coefficient as an imaging biomarker for predicting treatment response in head and neck cancer treated with chemoradiotherapy.Free-breathing 3D diffusion MRI for high-resolution hepatic metastasis characterization in small animals.The functional diffusion map: an imaging biomarker for the early prediction of cancer treatment outcome.Longitudinal diffusion tensor imaging in a rat brain glioma modelTemporal and dose dependence of T2 and ADC at 9.4 T in a mouse model following single fraction radiation therapy.Diffusion-weighted MRI for monitoring tumor response to photodynamic therapy.ADC response to radiation therapy correlates with induced changes in radiosensitivity.Diffusion weighted imaging in prostate cancer.Approaches and genetic determinants in predicting response to neoadjuvant chemotherapy in locally advanced gastric cancerApparent diffusion coefficient value of diffusion-weighted imaging for hepatocellular carcinoma: correlation with the histologic differentiation and the expression of vascular endothelial growth factorImaging in assessing hepatic and peritoneal metastases of gastric cancer: a systematic review.Measuring the apparent diffusion coefficient in primary rectal tumors: is there a benefit in performing histogram analyses?Correlation of diffusion-weighted imaging data with apoptotic and proliferation indexes in CT26 colorectal tumor homografts in balb/c mouse.Assessment of multiexponential diffusion features as MRI cancer therapy response metricsSupratentorial low-grade glioma resectability: statistical predictive analysis based on anatomic MR features and tumor characteristicsDW-MRI in assessment of the hypoxic fraction, interstitial fluid pressure, and metastatic propensity of melanoma xenografts.Diffusion-weighted MRI for selection of complete responders after chemoradiation for locally advanced rectal cancer: a multicenter study.High-field small animal magnetic resonance oncology studies.Automated prostate cancer detection using T2-weighted and high-b-value diffusion-weighted magnetic resonance imagingMeta-analysis of quantitative diffusion-weighted MR imaging in differentiating benign and malignant pancreatic masses.Tumour ADC measurements in rectal cancer: effect of ROI methods on ADC values and interobserver variability.Functional diffusion map as an early imaging biomarker for high-grade glioma: correlation with conventional radiologic response and overall survival.Differential diagnosis of axillary inflammatory and metastatic lymph nodes in rabbit models by using diffusion-weighted imaging: compared with conventional magnetic resonance imaging.Intra- and interobserver variability of whole-tumour apparent diffusion coefficient measurements in nephroblastoma: a pilot study.Apparent diffusion coefficient measurement covering complete tumor area better predicts rectal cancer response to neoadjuvant chemoradiotherapy.Assessment of early treatment response after CT-guided radiofrequency ablation of unresectable lung tumours by diffusion-weighted MRI: a pilot studyCombined value of apparent diffusion coefficient-standardized uptake value max in evaluation of post-treated locally advanced rectal cancer.Increased tumour ADC value during chemotherapy predicts improved survival in unresectable pancreatic cancerEwing sarcoma dissemination and response to T-cell therapy in mice assessed by whole-body magnetic resonance imagingEffect of b value on monitoring therapeutic response by diffusion-weighted imaging.Evaluation of treatment response in patients with metastatic renal cell carcinoma: role of state-of-the-art cross-sectional imaging.Tumor response assessments with diffusion and perfusion MRI.Dual-source parallel RF transmission for diffusion-weighted imaging of the abdomen using different b values: image quality and apparent diffusion coefficient comparison with conventional single-source transmission.Magnetic nanoparticles and their applications in image-guided drug delivery.Monitoring of the tumor response to nano-graphene oxide-mediated photothermal/photodynamic therapy by diffusion-weighted and BOLD MRI.Evaluation of treatment-associated inflammatory response on diffusion-weighted magnetic resonance imaging and 2-[18F]-fluoro-2-deoxy-D-glucose-positron emission tomography imaging biomarkers.Diffusion-weighted MRI in the detection of prostate cancer: meta-analysis.Extramural depth of tumor invasion at thin-section MR in rectal cancer: associating with prognostic factors and ADC value.Correlation of apparent diffusion coefficient measured by diffusion-weighted MRI and clinicopathologic features in pancreatic cancer patients.Differentiation of recurrent tumor and posttreatment changes in head and neck squamous cell carcinoma: application of high b-value diffusion-weighted imaging.
P2860
Q30666523-CF161633-B713-40EF-AA4A-34E78045A4AFQ31018721-8E488A12-C264-46A3-B7E0-15ACD01822D8Q31043513-86AB46CF-67DB-4382-A025-4FBD3C61B87DQ31155125-9B1735A8-D9AC-4BC7-B347-303031B59340Q33492874-B5649CC1-7695-468C-97A4-14D39E9B2E5BQ33647190-B4CA0DA7-EB88-4C84-808E-B52783F23B26Q33689750-B44A204D-40EA-43E9-BFD8-2BEAAC0AF7CBQ33714805-8940E84F-557A-4D9E-8A43-10B0B4F3079EQ33728359-A50E6A11-72DE-4336-AF4E-E8F416D1A01FQ33830807-8B39B8C6-D7C5-4C8A-821C-815A2E132CE6Q33840377-DB87F8A9-0549-457A-9577-4AADEC61A843Q33841515-FC45780D-0567-47EF-8D8F-C8D9122550B6Q33878704-0366E801-5383-448A-8441-CF06569ED0FAQ34249651-C8CED77B-7573-4E93-8A97-1C44D6E5671BQ34666800-F9D80CA8-E5F6-45FE-ACFB-DBA10E08E6C6Q35094559-2C94E208-A462-443D-80CB-A2CEBBA89C1DQ35106508-2A0FF61B-B004-4E7D-9659-3E1867FE8F0CQ35312455-4DD562F5-C806-4163-AF35-6FB6463013B3Q35465633-984E968A-4916-4315-A9A8-26D297A938A7Q35495731-71057EFE-7F95-4D4F-B2CA-4CCCF1AFBDD8Q35552604-DB47D712-4EDE-4F3B-9814-18F8EC4801F7Q35698555-42F6E400-873E-4E30-9A94-9FF12148A3F2Q36063206-BBD7AC85-76A4-4213-87A6-249126D06162Q36080093-0E738E28-11CA-4154-8C4F-C369EF5CFB71Q36307146-970C8FAA-3185-4A0C-B936-8D77BCFC6651Q36323691-AE149551-CE8A-4013-BC5A-9C857AECCCF0Q36419166-F4379574-5521-4429-871C-3717A52317DAQ36892277-9D2EE08D-BC87-4BD5-AA30-748D417CF304Q37081838-0E9CB345-F0AB-4558-8F07-ECE8D310A08CQ37362711-F64C0359-2D24-47CB-BD0F-A1E2E526BF18Q37965053-30E8C57C-33CB-4456-A251-29C6F0E3E036Q37995577-FAABE394-3FB3-4246-B05D-94BC6F0F9A61Q38055451-BBFA5341-5D7D-443B-B5FD-4FB1F4F3D53FQ38382957-7C181858-FDFD-4832-8604-59723FF51A9AQ38874949-F962FCE3-9405-4A64-AABA-5055BACF9085Q39747261-F5FC25FD-9F62-4998-8C5A-2CA43740A1FEQ41866423-51C61F23-8B6F-42B9-8FC3-0ACC89420720Q43478670-85D851CB-9424-487C-9008-D1DC79A76C55Q44247897-8D239D6B-329A-4780-9FB7-3FE0C95855CFQ44706519-BD54D2F3-2D85-4054-A707-D8827BA1BCEE
P2860
High-b-value diffusion-weighted MR imaging for pretreatment prediction and early monitoring of tumor response to therapy in mice.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
High-b-value diffusion-weighte ...... r response to therapy in mice.
@ast
High-b-value diffusion-weighte ...... r response to therapy in mice.
@en
type
label
High-b-value diffusion-weighte ...... r response to therapy in mice.
@ast
High-b-value diffusion-weighte ...... r response to therapy in mice.
@en
prefLabel
High-b-value diffusion-weighte ...... r response to therapy in mice.
@ast
High-b-value diffusion-weighte ...... r response to therapy in mice.
@en
P2093
P1433
P1476
High-b-value diffusion-weighte ...... r response to therapy in mice.
@en
P2093
Arie Orenstein
Genady Kostenich
Jack S Cohen
Jesus Ruiz-Cabello
Stephan E Maier
Thomas Tichler
Yael Mardor
Yiftach Roth
P304
P356
10.1148/RADIOL.2322030778
P407
P577
2004-06-23T00:00:00Z